These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 11822346

  • 1. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.
    Huse DM, Cummins G, Taylor DC, Russell MW.
    Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG.
    Eur J Med Res; 2004 Apr 30; 9(4):225-39. PubMed ID: 15210403
    [Abstract] [Full Text] [Related]

  • 8. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP, Bounameaux H.
    Thromb Haemost; 2002 Apr 30; 87(4):586-92. PubMed ID: 12008939
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A, Juárez S, Reche A, Gómez-Outes A, Martínez-González J, Fontcuberta J, ESFERA Investigators.
    Int J Clin Pract; 2006 May 30; 60(5):518-25. PubMed ID: 16700847
    [Abstract] [Full Text] [Related]

  • 12. Low molecular weight heparin versus unfractionated heparin in the colonoscopy peri-procedure period: a cost modeling study.
    Goldstein JL, Larson LR, Yamashita BD, Fain JM, Schumock GT.
    Am J Gastroenterol; 2001 Aug 30; 96(8):2360-6. PubMed ID: 11513175
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
    Nutescu EA, Shorr AF, Farrelly E, Horblyuk R, Happe LE, Franklin M.
    Ann Pharmacother; 2008 Sep 30; 42(9):1216-21. PubMed ID: 18611992
    [Abstract] [Full Text] [Related]

  • 15. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.
    Groce JB.
    Pharmacotherapy; 1998 Sep 30; 18(6 Pt 3):175S-180S. PubMed ID: 9853912
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.
    Rodger M, Bredeson C, Wells PS, Beck J, Kearns B, Huebsch LB.
    CMAJ; 1998 Oct 20; 159(8):931-8. PubMed ID: 9834718
    [Abstract] [Full Text] [Related]

  • 17. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program.
    Bridges GG, Lee MD, Jenkins JK, Stephens MA, Croce MA, Fabian TC.
    J Trauma; 2003 Feb 20; 54(2):232-5. PubMed ID: 12579045
    [Abstract] [Full Text] [Related]

  • 18. Early discharge of patients with venous thromboembolism: implications regarding therapy.
    Stein PD, Hull RD, Matta F, Yaekoub AY.
    Clin Appl Thromb Hemost; 2010 Apr 20; 16(2):141-5. PubMed ID: 19833629
    [Abstract] [Full Text] [Related]

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P, Behounek J, Skoták M, Nevsímal L.
    Acta Chir Orthop Traumatol Cech; 2004 Apr 20; 71(4):237-44. PubMed ID: 15456102
    [Abstract] [Full Text] [Related]

  • 20. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S, Laliberté F, Crivera C, Germain G, Bookhart BK, Olson WH, Schein J, Lefebvre P.
    Clin Ther; 2016 Aug 20; 38(8):1803-1816.e3. PubMed ID: 27491278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.